Opening Recap Market Pulse: Liquidity warnings from ex-Treasury official Richard Berner saps risk appetite and has traders trimming positions across the board. Key Movers: Blue-chip names took a holiday as funding concerns flared...
Category - Hot Stocks
CDE: Year-End 2025 Reserves Report Sparks Investor Interest!
Coeur Mining, Inc. (NYSE: CDE) – a U.S.-based gold and silver miner – delivered a bullish year-end 2025 mineral reserves update that has captured investors’ attention. The company reported proven & probable reserves of 4.4...
Bitcoin Boom-Bust Over? Energy Stocks Roar Higher
Good morning, movers and shakers. It’s Tuesday, Feb. 17, 2026. Here’s your straight-shooter recap of yesterday’s action and today’s game plan—market analysis, wealth building and profit strategy served straight. Market Pulse:...
AON: India’s Rafale Deal Sparks Major Growth Opportunity!
Introduction India’s massive Rafale fighter jet deal – valued at roughly 3.6 trillion rupees (≈$39.7 billion) – signals not only a defense boost but a surge in domestic aerospace activity (apnews.com). Aon plc (NYSE: AON), a...
Gold Outshines Bitcoin as Markets Brace for Fed
Market Pulse: Global markets drift as precious metals edge higher and crypto shows turbulence in the face of mixed headlines. Gold gets the spotlight as analysts echo Bob Murphy’s view on Crypto Briefing, while Bitcoin stumbles...
What Analysts Are Predicting for BMY—Don’t Miss Out!
Introduction Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company known for blockbuster drugs in oncology, cardiovascular, and immunology. Despite its strong portfolio, BMY’s stock performance has lagged the...
Gold Snoozes, Bitcoin Bounces Amid Policy Uncertainty
Opening Recap Market Pulse: Precious metals couldn’t break out of a tight range this weekend, with gold and silver futures stuck in a holding pattern on mixed economic signals and Washington theater. Key Movers: Gold’s...
MRK Gains FDA Approval for KEYTRUDA®—Big Opportunity!
Keytruda’s New Approval and Business Overview Merck & Co. (NYSE: MRK) has secured an important FDA approval for its blockbuster immunotherapy KEYTRUDA® (pembrolizumab) as a first-line treatment (with chemotherapy) for advanced or...
Magnesium Surge Meets Bitcoin’s Long-Shot Rebound
Opening Recap Market Pulse: Markets stalled in early trading as industrial metals and crypto took center stage—magnesium caught a wave of optimism while Bitcoin’s long-shot rebound held traders on edge. Key Movers: ‘Magnesium...
EBS: FDA Approves NARCAN® Multipacks—Act Now!
Overview Emergent BioSolutions (NYSE: EBS) is a specialty biopharma company focused on public health threats and countermeasures. Its portfolio ranges from vaccines for bioterror agents (like anthrax and smallpox) to emergency...

